Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

190

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09DB07	CANDAM	G	Candesartan cilexetil - 8mg, Amlodipine - 5mg		Capsule, hard	923,220 L.L
D04AA32	DERMAMINE ITCH STOPPING	G	Diphenhydramine HCl - 1%, Zinc acetete - 0.1%		Cream	560,382 L.L
H02AB08	TRIACORT	G	Triamcinolone acetonide - 40mg/ml	40mg/ml	Injectable suspension	745,833 L.L
J02AC02	FONGINOX	G	Itraconazole - 100mg	100mg	Capsule	174,060 L.L
L01BC06	CAPEDA	G	Capecitabine - 500mg	500mg	Tablet, film coated	4,927,423 L.L
M02AA15	CLOFEN	G	Diclofenac sodium (diethylamine) - 10mg/g	1%	Creamagel	210,983 L.L
S01AE07	IMOX	G	Moxifloxacin (HCl) - 0.5%	0.5%	Drops	464,970 L.L
A10BB12	JOSWE GLEMAX 4	G	Glimepiride - 4mg	4mg	Caplet	235,172 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml		Injectable solution	226,388 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LS3	G	Potassium chloride - K+:2.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.60 mmol/l, Sodium acetate - Cl-:112 mmol/l, Sodium chloride - Na+:140 mmol/l		Injectable solution	L.L
C08CA01	NIPIDOL	G	Amlodipine - 5mg	5mg	Tablet	255,330 L.L
C09DB07	CORONOPINE	G	Candesartan cilexetil - 8mg, Amlodipine - 5mg		Capsule, hard	1,368,032 L.L
D04AA32	HISTERGAN	G	Diphenhydramine HCl - 2%	2%	Cream	546,944 L.L
G03AD01	EZ-ONE	G	Levonorgestrel - 1.5mg	1.5mg	Tablet	722,987 L.L
H02AB09	HYDROCORTISON VUAB	G	Hydrocortisone hydrogenosuccinate - 100mg	100mg	Injectable dry powder for solution	147,823 L.L
J02AC02	ITRAZOL	G	Itraconazole - 100mg	100mg	Capsule	149,167 L.L
L01BC06	DIROGIT	G	Capecitabine - 500mg	500mg	Tablet, film coated	11,330,804 L.L
M02AA15	DICLOGESIC	G	Diclofenac sodium (diethylamine) - 10mg/g	1%	Gel	135,728 L.L
N02BE01	KIDOL-OR	G	Paracetamol - 240mg/5ml	240mg/5ml	Elixir	314,843 L.L
R03BA02	BUDESONIDE ARROW	G	Budesonide - 1mg/2ml	1mg/2ml	Inhalation suspension for nebuliser	1,342,499 L.L
S01AE07	MOXITEC	G	Moxifloxacin (HCl) - 5mg/ml	5mg/ml	Drops solution	464,970 L.L
A10BB12	ORBIDE	G	Glimepiride - 4mg	4mg	Tablet	357,078 L.L
B01AB11	ANGIOFLUX	G	Sulodexide - 250LRU	250LRU	Capsule, soft	2,026,514 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml		Injectable solution	153,990 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS R	G	Potassium chloride - K+:1.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.40 mmol/l, Sodium acetate - Cl-:105.8 mmol/l, Sodium chloride - Na+:140.5 mmol/l		Injectable solution	L.L
C08CA01	TORANS	G	Amlodipine (besylate) - 5mg	5mg	Tablet	518,339 L.L
C09DB07	CANDAM	G	Candesartan cilexetil - 16mg, Amlodipine - 5mg		Capsule, hard	923,220 L.L
D04AA32	HISTAFEN	G	Diphenhydramine HCl - 2%	2%	Solution	362,837 L.L
G03AD01	PURPLE LINE	G	Levonorgestrel - 1.5mg	1.5mg	Tablet, film coated	1,071,570 L.L
H02AB09	HYDROCORTISONE ORBUCELL	G	Hydrocortisone (sodium succinate) - 100mg	100mg	Injectable powder	1,091,712 L.L

...

190